Dx dialogues: post anti-CD38 therapy
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: changes in treatment sequencing for metastatic breast cancer
My experience being diagnosed with multiple myeloma
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Advocating for yourself with multiple myeloma
Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML
Dx dialogues: advancements in treating indolent systemic mastocytosis
Black patients have an increased risk of getting multiple myeloma and dying from it. Here’s why and what can be done.
What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.
An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.
Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.
Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.